Researcher: FDA Uses “Preposterous” Analysis to Approve Vaccines for Kids
Health and Science Must Read
In an article entitled, “Ten red flags in the FDA’s risk-benefit analysis of Pfizer’s EUA application to inject American children 5 to 11 with its mRNA product,” PhD researcher Toby Rogers exposes what he describes as “junk science” within the Food and Drug Administration’s risk-benefit analysis that led to th…